Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Hematologic Diseases × Filgrastim × Clear all

Status

Sponsor Class

Study Type

Interventional 2 Observational 1

Sponsor

Conditions

Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Lymphoma 1 Lung Neoplasms 1 Hodgkin Disease 1 Hematologic Diseases 1 Fallopian Tube Neoplasms 1 Breast Neoplasms 1

Interventions

Watchful Waiting 2 Blood Specimen Collection 2 Rituximab 1 Observation 1 Interviews as Topic 1 Flow Cytometry 1 Filgrastim 1 Data Collection 1 COVID-19 Vaccines 1 Bortezomib 1 Blood Viscosity 1 Albumins 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02806791 2016-06-21

Efficacy of Biosimilar Filgrastim on the Mobilization of Hematopoietic Stem Cell CD34+ (Cluster of Differentiation 34) and on the Kinetic Engraftment

Azienda Ospedaliera San Giovanni Battista

Hematologic Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡